Zobrazeno 1 - 10
of 124
pro vyhledávání: '"Percent Free Prostate-Specific Antigen"'
Autor:
Hiroaki Iwamoto, Kouji Izumi, Suguru Kadomoto, Tomoyuki Makino, Renato Naito, Hiroshi Yaegashi, Kazuyoshi Shigehara, Yoshifumi Kadono, Atsushi Mizokami
Publikováno v:
Asian Journal of Andrology, Vol 23, Iss 1, Pp 36-40 (2021)
A standard modality for prostate cancer detection in men 75 years and older has not been established. A simple screening method for elderly patients is needed to avoid unnecessary biopsies and to effectively diagnose prostate cancer. A retrospective
Externí odkaz:
https://doaj.org/article/bd5b4fbd7b9949c2adc14fe0b12f495f
Autor:
Rui Chen, Li-Qun Zhou, Xiao-Bing Cai, Li-Ping Xie, Yi-Ran Huang, Da-Lin He, Xu Gao, Chuan-Liang Xu, Qiang Ding, Qiang Wei, Chang-Jun Yin, Shan-Cheng Ren, Fu-Bo Wang, Ye Tian, Zhong-Quan Sun, Qiang Fu, Lu-Lin Ma, Jun-Hua Zheng, Zhang-Qun Ye, Ding-Wei Ye, Dan-Feng Xu, Jian-Quan Hou, Ke-Xin Xu, Jian-Lin Yuan, Xin Gao, Chun-Xiao Liu, Tie-Jun Pan, Ying-Hao Sun, on behalf of Chinese Prostate Cancer Consortium
Publikováno v:
Asian Journal of Andrology, Vol 17, Iss 6, Pp 1017-1021 (2015)
Percent free prostatic-specific antigen (%fPSA) has been introduced as a tool to avoid unnecessary biopsies in patients with a serum PSA level of 4.0-10.0 ng ml−1 , however, it remains controversial whether %fPSA is effective in PSA range of 10.1-2
Externí odkaz:
https://doaj.org/article/96a61c0ae72e4bc2bc900734591d98fe
Autor:
Renato Naito, Tomoyuki Makino, Kazuyoshi Shigehara, Hiroshi Yaegashi, Hiroaki Iwamoto, Kouji Izumi, Suguru Kadomoto, Yoshifumi Kadono, Atsushi Mizokami
Publikováno v:
Asian Journal of Andrology
Asian Journal of Andrology, Vol 23, Iss 1, Pp 36-40 (2021)
Asian Journal of Andrology, Vol 23, Iss 1, Pp 36-40 (2021)
A standard modality for prostate cancer detection in men 75 years and older has not been established. A simple screening method for elderly patients is needed to avoid unnecessary biopsies and to effectively diagnose prostate cancer. A retrospective
Autor:
Alexandre R. Zlotta, Guan Hee Tan, Antonio Finelli, Neil Fleshner, Thenappan Chandrasekar, Hanan Goldberg, Eleftherios Diamantis, Gregory J. Nason, Dixon T.S. Woon, Alejandro Berlin, Omar Alhunaidi, Emily Whelan, Hina Shiakh, Jaime O. Herrera-Caceres, Khaled Ajib
Publikováno v:
Journal of Urology. 204:289-295
The role of percent free prostate specific antigen (%fPSA) in patients who have undergone radical prostatectomy and subsequently experienced disease relapse is unclear. We previously conducted 2 retrospective studies and found %fPSA 15 or greater in
Publikováno v:
Journal of Urology. 205:276-277
Publikováno v:
Journal of Urology. 205:277-277
Autor:
Javier Hernandez, Ian M. Thompson, Robin J. Leach, Donna P. Ankerst, Jonathan Gelfond, Jesús Salinas Herrera, Andreas N. Strobl, Martin Goros
Publikováno v:
Journal of Urology. 196:355-360
We characterized the diagnostic properties of serial percent free prostate specific antigen in relation to prostate specific antigen in a multiethnic, multiracial cohort of healthy men.A total of 6,982 percent free prostate specific antigen and prost
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Bi-Ming He, Lulin Ma, Kexin Xu, Chuanliang Xu, Chunxiao Liu, Fubo Wang, Zhangqun Ye, Shancheng Ren, Yi-Ran Huang, Jianquan Hou, Xiaobing Cai, Yinghao Sun, Qiang Fu, Pengfei Shao, Xu Gao, Li Lu, Jianlin Yuan, Liping Xie, Rui Chen, Dalin He, Dingwei Ye, Tie Zhou, Liqun Zhou, Danfeng Xu
Publikováno v:
Asian Journal of Urology
Objective To test the diagnostic performance of percent free prostate-specific antigen (%fPSA) in predicting any prostate cancer (PCa) and high-grade prostate cancer (HGPCa) in a retrospective multi-center biopsy cohort with a PSA level of 4.0–10.0
Autor:
John T. Wei, William J. Catalona, Daniel W. Chan, Chris H. Bangma, Ron H.N. van Schaik, Stacy Loeb, George G. Klee, Lori J. Sokoll, Amabelle B. Cruz, Isaac A. Mizrahi, Martin G. Sanda, Kevin M. Slawin, Sanghyuk S. Shin, Alan W. Partin, Dennis L. Broyles, Leonard S. Marks
Publikováno v:
Journal of Urology, 193(4), 1163-1169. Elsevier Inc.
The Journal of urology, vol 193, iss 4
The Journal of urology, vol 193, iss 4
Purpose: The Prostate Health Index (phi) is a new test combining total, free and [-2] proPSA into a single score. It was recently approved by the FDA and is now commercially available in the U.S., Europe and Australia. We investigate whether phi impr